Difficulties in Performing Mesalazine Enemas and Factors Related to Discontinuation Among Patients With Ulcerative Colitis

Aki Kawakami, Makoto Tanaka, Ryota Ochiai, Makoto Naganuma, Reiko Kunisaki, Keiko Kazuma

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Current first-line treatment of ulcerative colitis consists of a combination of mesalazine enemas and oral mesalazine; however, many patients may discontinue mesalazine enemas. In this single-center, cross-sectional study, 165 outpatients with ulcerative colitis completed a self-administered questionnaire regarding the frequency of mesalazine enemas, difficulties in performing these enemas, and factors possibly associated with their discontinuation, as well as patient clinical and demographic characteristics. Of 165 patients, 34 (20.6%) discontinued mesalazine enemas because of a lack of efficacy. Five of the 13 items assessing difficulties were answered affirmatively by the majority of patients. Discontinuation of enema application was associated with a perceived lack of efficacy, four or more bowel movements per day, and lower scores on measurement of the doctor–patient relationship. Application of mesalazine enemas by patients with ulcerative colitis may be improved by discussions with peers and healthcare professionals and by adjusting the frequency of application or the time of starting the enema based on worsening of ulcerative colitis.

Original languageEnglish
JournalGastroenterology Nursing
DOIs
Publication statusAccepted/In press - 2016 Aug 3

Fingerprint

Mesalamine
Enema
Ulcerative Colitis
Outpatients
Cross-Sectional Studies
Demography
Delivery of Health Care

ASJC Scopus subject areas

  • Gastroenterology
  • Advanced and Specialised Nursing

Cite this

Difficulties in Performing Mesalazine Enemas and Factors Related to Discontinuation Among Patients With Ulcerative Colitis. / Kawakami, Aki; Tanaka, Makoto; Ochiai, Ryota; Naganuma, Makoto; Kunisaki, Reiko; Kazuma, Keiko.

In: Gastroenterology Nursing, 03.08.2016.

Research output: Contribution to journalArticle

@article{b6517ba2e8694beea0a1c82e9609bc03,
title = "Difficulties in Performing Mesalazine Enemas and Factors Related to Discontinuation Among Patients With Ulcerative Colitis",
abstract = "Current first-line treatment of ulcerative colitis consists of a combination of mesalazine enemas and oral mesalazine; however, many patients may discontinue mesalazine enemas. In this single-center, cross-sectional study, 165 outpatients with ulcerative colitis completed a self-administered questionnaire regarding the frequency of mesalazine enemas, difficulties in performing these enemas, and factors possibly associated with their discontinuation, as well as patient clinical and demographic characteristics. Of 165 patients, 34 (20.6{\%}) discontinued mesalazine enemas because of a lack of efficacy. Five of the 13 items assessing difficulties were answered affirmatively by the majority of patients. Discontinuation of enema application was associated with a perceived lack of efficacy, four or more bowel movements per day, and lower scores on measurement of the doctor–patient relationship. Application of mesalazine enemas by patients with ulcerative colitis may be improved by discussions with peers and healthcare professionals and by adjusting the frequency of application or the time of starting the enema based on worsening of ulcerative colitis.",
author = "Aki Kawakami and Makoto Tanaka and Ryota Ochiai and Makoto Naganuma and Reiko Kunisaki and Keiko Kazuma",
year = "2016",
month = "8",
day = "3",
doi = "10.1097/SGA.0000000000000147",
language = "English",
journal = "Gastroenterology Nursing",
issn = "1042-895X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Difficulties in Performing Mesalazine Enemas and Factors Related to Discontinuation Among Patients With Ulcerative Colitis

AU - Kawakami, Aki

AU - Tanaka, Makoto

AU - Ochiai, Ryota

AU - Naganuma, Makoto

AU - Kunisaki, Reiko

AU - Kazuma, Keiko

PY - 2016/8/3

Y1 - 2016/8/3

N2 - Current first-line treatment of ulcerative colitis consists of a combination of mesalazine enemas and oral mesalazine; however, many patients may discontinue mesalazine enemas. In this single-center, cross-sectional study, 165 outpatients with ulcerative colitis completed a self-administered questionnaire regarding the frequency of mesalazine enemas, difficulties in performing these enemas, and factors possibly associated with their discontinuation, as well as patient clinical and demographic characteristics. Of 165 patients, 34 (20.6%) discontinued mesalazine enemas because of a lack of efficacy. Five of the 13 items assessing difficulties were answered affirmatively by the majority of patients. Discontinuation of enema application was associated with a perceived lack of efficacy, four or more bowel movements per day, and lower scores on measurement of the doctor–patient relationship. Application of mesalazine enemas by patients with ulcerative colitis may be improved by discussions with peers and healthcare professionals and by adjusting the frequency of application or the time of starting the enema based on worsening of ulcerative colitis.

AB - Current first-line treatment of ulcerative colitis consists of a combination of mesalazine enemas and oral mesalazine; however, many patients may discontinue mesalazine enemas. In this single-center, cross-sectional study, 165 outpatients with ulcerative colitis completed a self-administered questionnaire regarding the frequency of mesalazine enemas, difficulties in performing these enemas, and factors possibly associated with their discontinuation, as well as patient clinical and demographic characteristics. Of 165 patients, 34 (20.6%) discontinued mesalazine enemas because of a lack of efficacy. Five of the 13 items assessing difficulties were answered affirmatively by the majority of patients. Discontinuation of enema application was associated with a perceived lack of efficacy, four or more bowel movements per day, and lower scores on measurement of the doctor–patient relationship. Application of mesalazine enemas by patients with ulcerative colitis may be improved by discussions with peers and healthcare professionals and by adjusting the frequency of application or the time of starting the enema based on worsening of ulcerative colitis.

UR - http://www.scopus.com/inward/record.url?scp=84982794752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982794752&partnerID=8YFLogxK

U2 - 10.1097/SGA.0000000000000147

DO - 10.1097/SGA.0000000000000147

M3 - Article

C2 - 27490278

AN - SCOPUS:84982794752

JO - Gastroenterology Nursing

JF - Gastroenterology Nursing

SN - 1042-895X

ER -